Investors/Novartis Venture Fund

2 London Mempool companies backed by Novartis Venture Fund

Rank =208 of 430 on the investor leaderboard. A source says it led a round in 1 of them.

See them on the mapCounts only deals named in a source we fetched

Inner London. Coloured dots are the portfolio, grey dots the rest of the map.

Portfolio by sector

Health22 Health companies

Portfolio on the map (2)

AstronauTx£48M
Biotech developing drugs that improve sleep architecture to treat Alzheimer's, Parkinson's and other neurological disorders.
Health · Neuroscience biotech · Up and comingLed a round
source: svhealthinvestors.com
Epsilogen
Develops IgE, IgA and IgG antibody therapeutics for cancer, with lead candidate MOv18 IgE in a Phase Ib trial in platinum-resistant ovarian cancer.
Health · Cancer antibodies · Up and coming
source: samedanltd.com

We list Novartis Venture Fund on a company only when a page we fetched names it as an investor. Its real London portfolio is likely bigger. Know a deal we missed? Suggest a fix with a source. How we count